CTOs on the Move

Westlake Medical Research

www.wmresearch.com

 
Westlake Medical Research is a Westlake Village, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.wmresearch.com
  • 1250 La Venta Dr Ste 101a
    Westlake Village, CA USA 91361
  • Phone: 805.496.3322

Executives

Name Title Contact Details

Similar Companies

Swisher Memorial Hospital

Swisher Memorial Hospital District's mission is to improve our quality of care and increase our services to meet the increasing healthcare demands for Swisher County and surrounding counties.

Alana Healthcare

Alana HealthCare, LLC, headquartered in Nashville, Tennessee, is a health solutions company that provides services to individuals with chronic and complex life conditions.

Addiction Recovery Care

Addiction Recovery Care provides residential and outpatient drug and alcohol addiction treatment.

Browns Medical Imaging

Browns Medical Imaging is a Omaha, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ContraVir Pharmaceuticals, Inc

ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.